0001596771-20-000121.txt : 20201120 0001596771-20-000121.hdr.sgml : 20201120 20201120152156 ACCESSION NUMBER: 0001596771-20-000121 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 EFFECTIVENESS DATE: 20201120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ocuphire Pharma, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-381168 FILM NUMBER: 201332144 BUSINESS ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 37000 GRAND RIVER AVE. STREET 2: SUITE 120 CITY: FARMINGTON HILLS STATE: MI ZIP: 48335 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 D 1 primary_doc.xml X0708 D LIVE 0001228627 Ocuphire Pharma, Inc. 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI MICHIGAN 48335 248-681-9815 DELAWARE REXAHN PHARMACEUTICALS, INC. CORPORATE ROAD SHOW DOT COM INC Corporation true Mina Sooch c/o Ocuphire Pharma, Inc. 37000 Grand River Ave., Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Director Alan R. Meyer c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Sean Ainsworth c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director James S. Manuso c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Cam Gallagher c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Susan K. Benton c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Richard J. Rodgers c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Director Bernhard Hoffmann c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Amy Zaremba Rabourn c/o Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI MICHIGAN 48335 Executive Officer Biotechnology Decline to Disclose 06b false 2020-11-05 false true true true true In connection with the merger between Ocuphire and Rexahn Pharmaceuticals Inc., Ocuphire entered into a securities purchase agreement providing for the issuance of Ocuphire common stock and warrants to purchase Rexahn common stock to accredited investors. 0 Cantor Fitzgerald & Co. 134 None None 110 East 59th Street 4th Floor New York NY NEW YORK 10022 IL ILLINOIS MD MARYLAND AZ ARIZONA NY NEW YORK MI MICHIGAN CA CALIFORNIA false Canaccord Genuity LLC 1020 None None 535 Madison Avenue New York NY NEW YORK 10022 IL ILLINOIS MD MARYLAND AZ ARIZONA NY NEW YORK MI MICHIGAN CA CALIFORNIA false 21150000 21150000 0 false 18 1600000 true 0 0 false Ocuphire Pharma, Inc. /s/ Bernhard Hoffmann Bernhard Hoffmann VP - Corporate Development and Finance 2020-11-20